首页> 美国卫生研究院文献>Biochemical Journal >Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.
【2h】

Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.

机译:α2半胱氨酸蛋白酶抑制剂和人血清中低Mr半胱氨酸蛋白酶抑制剂对人肝组织蛋白酶L的抑制作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The inhibition of human liver cathepsin L by two specific proteinase inhibitors present in human serum, namely alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine-proteinase inhibitor, was studied. Kinetic parameters, including inhibition constants (Ki) and rate constants for association and dissociation (k+1 and K-1), were determined. The values found are consistent with a possible physiological function of these inhibitors to control cathepsin L activity. Furthermore, a transfer of active proteinase from the complex with either cysteine-proteinase inhibitor species to alpha 2-macroglobulin was demonstrated in vitro. Given the rate of dissociation of both cathepsin-L-cysteine-proteinase inhibitor complexes, a function of transitory inhibitor can therefore be hypothesized for these proteins and might then provide an explanation of the clearance of lysosomal proteinases.
机译:研究了人类血清中存在的两种特异性蛋白酶抑制剂,即α2半胱氨酸蛋白酶抑制剂和低Mr半胱氨酸蛋白酶抑制剂对人肝组织蛋白酶L的抑制作用。确定动力学参数,包括抑制常数(Ki)和缔合和解离速率常数(k + 1和K-1)。发现的值与这些抑制剂控制组织蛋白酶L活性的可能的生理功能一致。此外,在体外证明了活性蛋白酶从具有半胱氨酸蛋白酶抑制剂物质的复合物中转移至α2-巨球蛋白。给定两种组织蛋白酶-L-半胱氨酸-蛋白酶抑制剂复合物的解离速率,因此可以假设这些蛋白具有瞬时抑制剂的功能,然后可以解释溶酶体蛋白酶的清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号